Protecting

Future Generations.

In 2019, an estimated 5.2 million children under the age of 5 years old died mostly from preventable and treatable causes, with newborns (under 28 days) accounting for 2.4 million of these deaths. Neonatal sepsis, a blood infection in newborns, is a leading cause of death in this population. Antimicrobial resistance is an increasing global concern, with up to 30% of all deaths related to infections in newborns are thought to be directly caused by multi-drug resistant bacteria.

The CNPI AMR team at St George’s, University of London conduct ground breaking research investigating into novel treatments and prevention methods against diseases caused by antimicrobial resistant organisms. The research conducted at SGUL includes a series of clinical and observational studies investigating into microbes that cause disease and death in infancy. This includes studies looking at the impact of the use and consumption of antimicrobial therapy in different settings across the world, aiming to develop and deliver new treatments, policies and guidelines for the management of infections in places with high emerging drug resistance.

Antimicrobial Resistance Group

The Serious Bacterial Infections in Neonates and Children and Antimicrobial Resistance (AMR) Research Group.

We lead on global research including observational and interventional trials focusing on novel strategies to prevent colonisation and disease caused by multi-drug resistant (MDR) pathogens.

Read about the research we are currently conducting globally to support trial planning and hypothesis generation, and provide an evidence base for conducting antibiotic interventional clinical trials.

Read about our previous research, interpretations of the results and conclusions which can be used to influence future research and global policy.

Meet the team leading on global AMR research at the CNPI, St George's, University of London.

A Global
Footprint

Select the map to view our partners that we are working with on research globally.

View Partners

Recent News

Read about all the latest information from AMR.

September 13, 2023 in Announcements, Research

PediCAP Trial completes recruitment!

The PediCAP team is pleased to report that the 1100 patients required for the main trial in this…
Read More
June 13, 2023 in Announcements, Research

AWaRe Book Webinar!

On Monday the 12th of June, our AMR team launched the World Health Organization #AWaRe Book Webinar in collaboration…
Read More

On Social

Follow us on twitter for the latest updates.

In this week's OWOH #podcast, @AislinnCook of @CNPI_AMR & @HERC_Oxford tells us some concrete achievable goals she & co-authors of @TheLancet series on #AMR found that the world can work toward to control the spread of drug-resistant germs. Listen here: https://onehealthtrust.org/news-media/podcasts/targeting-drug-resistance-achievable-goals-to-keep-antibiotics-working/

Load More